Company profile CYTH
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Cyclo Therapeutics expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 71 | 125 76.1% QoQ | 0 -100.0% QoQ | 88 inf% QoQ |
| 2020 | 47 -33.8% YoY -46.6% QoQ | 30 -76.0% YoY -36.2% QoQ | 46 inf% YoY 53.3% QoQ | 220 150.0% YoY 378.3% QoQ |
| 2021 | 266 466.0% YoY 20.9% QoQ | 164 446.7% YoY -38.3% QoQ | 163 254.3% YoY -0.6% QoQ | 80 -63.6% YoY -50.9% QoQ |
| 2022 | 214 -19.5% YoY 167.5% QoQ | 86 -47.6% YoY -59.8% QoQ | 192 17.8% YoY 123.3% QoQ | 178 122.5% YoY -7.3% QoQ |
| 2023 | 52 -75.7% YoY -70.8% QoQ | 107 24.4% YoY 105.8% QoQ | 63 -67.2% YoY -41.1% QoQ | 179 0.6% YoY 184.1% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Cyclo Therapeutics was 9.08 per week. The last year interest of Cyclo Therapeutics compared to the last 5 years has changed by -22.47%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 28.94%.
There is not enough data for Trappsol Cyclo to provide analysis
There is not enough data for Trappsol Cyclo to provide correlation calculation
There is not enough data for Trappsol Cyclo to provide analysis
After 34 days of this quarter the interest is at 91.0. Based on that we can calculate that during remaining 58 days it will total up to 246.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 48 |
| 2019 | 161 235.4% QoQ | 105 -34.8% QoQ | 165 57.1% QoQ | 258 437.5% YoY 56.4% QoQ |
| 2020 | 149 -7.5% YoY -42.2% QoQ | 82 -21.9% YoY -45.0% QoQ | 102 -38.2% YoY 24.4% QoQ | 168 -34.9% YoY 64.7% QoQ |
| 2021 | 87 -41.6% YoY -48.2% QoQ | 74 -9.8% YoY -14.9% QoQ | 64 -37.3% YoY -13.5% QoQ | 61 -63.7% YoY -4.7% QoQ |
| 2022 | 240 175.9% YoY 293.4% QoQ | 101 36.5% YoY -57.9% QoQ | 233 264.1% YoY 130.7% QoQ | 210 244.3% YoY -9.9% QoQ |
| 2023 | 198 -17.5% YoY -5.7% QoQ | 0 -100.0% YoY -100.0% QoQ | 198 -15.0% YoY inf% QoQ | 91 -56.7% YoY -54.0% QoQ |
The average 5 years interest of Niemann-Pick Type C disease was 10.75 per week. The last year interest of Niemann-Pick Type C disease compared to the last 5 years has changed by 3.07%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 8.52%.
After 34 days of this quarter the interest is at 159.0. Based on that we can calculate that during remaining 58 days it will total up to 430.0. Alzheimer's disease treatment expected interest is significantly higher compared to previous quarter (+inf%) and same quarter last year (+inf%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 177 |
| 2019 | 176 -0.6% QoQ | 151 -14.2% QoQ | 237 57.0% QoQ | 286 61.6% YoY 20.7% QoQ |
| 2020 | 277 57.4% YoY -3.1% QoQ | 184 21.9% YoY -33.6% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2023 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 159 inf% YoY inf% QoQ |
The average 5 years interest of Alzheimer's disease treatment was 6.31 per week. The last year interest of Alzheimer's disease treatment compared to the last 5 years has changed by -51.51%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -80.88%.
There is not enough data for Cyclodextrin-based products to provide analysis
There is not enough data for Cyclodextrin-based products to provide correlation calculation
There is not enough data for Cyclodextrin-based products to provide analysis
There is not enough data for Cyclo Therapeutics clinical trials to provide analysis
There is not enough data for Cyclo Therapeutics clinical trials to provide correlation calculation
There is not enough data for Cyclo Therapeutics clinical trials to provide analysis
There is not enough data for Neurodegenerative disease treatments to provide analysis
There is not enough data for Neurodegenerative disease treatments to provide correlation calculation
There is not enough data for Neurodegenerative disease treatments to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Cyclo Therapeutics stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 25 | 44 76.0% QoQ | 71 61.4% QoQ | 105 47.9% QoQ |
| 2020 | 15 -40.0% YoY -85.7% QoQ | 119 170.5% YoY 693.3% QoQ | 72 1.4% YoY -39.5% QoQ | 77 -26.7% YoY 6.9% QoQ |
| 2021 | 45 200.0% YoY -41.6% QoQ | 45 -62.2% YoY 0.0% QoQ | 69 -4.2% YoY 53.3% QoQ | 68 -11.7% YoY -1.4% QoQ |
| 2022 | 65 44.4% YoY -4.4% QoQ | 36 -20.0% YoY -44.6% QoQ | 63 -8.7% YoY 75.0% QoQ | 45 -33.8% YoY -28.6% QoQ |
| 2023 | 90 38.5% YoY 100.0% QoQ | 67 86.1% YoY -25.6% QoQ | 186 195.2% YoY 177.6% QoQ | 68 51.1% YoY -63.4% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Cyclo Therapeutics stock was 5.27 per week. The last year interest of Cyclo Therapeutics stock compared to the last 5 years has changed by 43.45%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 60.51%.
There is not enough data for Cyclo Therapeutics contact information to provide analysis
There is not enough data for Cyclo Therapeutics contact information to provide correlation calculation
There is not enough data for Cyclo Therapeutics contact information to provide analysis
There is not enough data for Cyclo Therapeutics Florida to provide analysis
There is not enough data for Cyclo Therapeutics Florida to provide correlation calculation
There is not enough data for Cyclo Therapeutics Florida to provide analysis